Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2021

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2021

Table of Contents
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Scope
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016 & 2021 & 2027)
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trends (2016-2027)
2 Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Forecasts by Region
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2021)
2.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2016-2021)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.6 India Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Competition Landscape by Players
3.1 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players by Sales (2016-2021)
3.2 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players by Revenue (2016-2021)
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2020)
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Company (2016-2021)
3.5 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Review by Type (2016-2021)
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2016-2021)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2016-2021)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2022-2027)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Type (2022-2027)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2022-2027)
5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Review by Application (2016-2021)
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2016-2021)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2016-2021)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2022-2027)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Application (2022-2027)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2022-2027)
6 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
6.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
6.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2016-2021)
6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2022-2027)
7 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
7.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
7.3.1 Europe 123 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 123 Sales Breakdown by Application (2022-2027)
8 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
8.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
8.1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
8.1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
8.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
8.2.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
8.2.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
8.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)
9 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
9.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
9.1.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
9.1.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
9.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
9.2.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
9.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
10.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
10.1.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
10.1.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
10.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
10.2.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
11.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
11.1.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
11.1.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
11.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
11.2.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
11.2.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
11.3 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
11.3.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2016-2021)
11.3.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Non-steroidal Anti-inflammatory Drugs (NSAID) Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.1.5 Bayer Recent Development
12.2 Ecotrin
12.2.1 Ecotrin Corporation Information
12.2.2 Ecotrin Business Overview
12.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.2.5 Ecotrin Recent Development
12.3 Generic
12.3.1 Generic Corporation Information
12.3.2 Generic Business Overview
12.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.3.5 Generic Recent Development
12.4 St. Joseph
12.4.1 St. Joseph Corporation Information
12.4.2 St. Joseph Business Overview
12.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.4.5 St. Joseph Recent Development
12.5 Elanco
12.5.1 Elanco Corporation Information
12.5.2 Elanco Business Overview
12.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.5.5 Elanco Recent Development
12.6 Zoetis
12.6.1 Zoetis Corporation Information
12.6.2 Zoetis Business Overview
12.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.6.5 Zoetis Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Corporation Information
12.7.2 Boehringer Ingelheim Business Overview
12.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.7.5 Boehringer Ingelheim Recent Development
12.8 Merial
12.8.1 Merial Corporation Information
12.8.2 Merial Business Overview
12.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.8.5 Merial Recent Development
12.9 Merck Animal Health
12.9.1 Merck Animal Health Corporation Information
12.9.2 Merck Animal Health Business Overview
12.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.9.5 Merck Animal Health Recent Development
13 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
13.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
14.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
15 Market Dynamics
15.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
15.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Drivers
15.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
15.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Region (2016-2021)
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2021)
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Region (2016-2021)
Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Company (2016-2021)
Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Company (2016-2021)
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2020)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites and Area Served
Table 19. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2016-2021)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2016-2021)
Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2022-2027)
Table 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2022-2027)
Table 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2016-2021)
Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2016-2021)
Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2022-2027)
Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2022-2027)
Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2022-2027)
Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 39. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 40. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 42. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 43. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 44. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 45. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 46. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 47. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 48. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 49. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 52. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 54. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 56. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 58. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 60. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 62. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 63. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 64. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 66. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 67. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 68. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 69. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 70. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 71. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 72. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 73. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 74. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 75. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 76. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 78. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 80. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 82. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 84. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 98. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 99. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 100. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 102. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 103. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 104. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 105. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 106. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 107. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 108. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 109. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 114. Bayer Recent Development
Table 115. Ecotrin Corporation Information
Table 116. Ecotrin Description and Business Overview
Table 117. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 119. Ecotrin Recent Development
Table 120. Generic Corporation Information
Table 121. Generic Description and Business Overview
Table 122. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 124. Generic Recent Development
Table 125. St. Joseph Corporation Information
Table 126. St. Joseph Description and Business Overview
Table 127. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 129. St. Joseph Recent Development
Table 130. Elanco Corporation Information
Table 131. Elanco Description and Business Overview
Table 132. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 134. Elanco Recent Development
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Business Overview
Table 137. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 139. Zoetis Recent Development
Table 140. Boehringer Ingelheim Corporation Information
Table 141. Boehringer Ingelheim Description and Business Overview
Table 142. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 144. Boehringer Ingelheim Recent Development
Table 145. Merial Corporation Information
Table 146. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Merial Description and Business Overview
Table 148. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 149. Merial Recent Development
Table 150. Merck Animal Health Corporation Information
Table 151. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Merck Animal Health Description and Business Overview
Table 153. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 154. Merck Animal Health Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 158. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
Table 159. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 160. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Table 161. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 162. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2021 & 2027
Figure 3. Salicylates Product Picture
Figure 4. Propionic acid derivatives Product Picture
Figure 5. Acetic aci

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs